GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

GSK said it remains confident in its ability to absorb the financial impact of potential US pharmaceutical tariffs as it ...

British drugmaker GSK insisted it was “well positioned” to respond to the impact of sector-specific tariffs amid widespread ...

UK drugmaker GSK ended Tuesday’s trading more than 2% higher after announcing its first-quarter financial results.

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

P innovation’s new, generic next-generation dry powder inhaler (DPI) filling technology has become available on the market.

WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to control their asthma after a ...

A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to imposing tariffs ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

GSK posted adjusted earnings per share of $1.20, surpassing the consensus estimate of $1.02. Revenue for the quarter came in at $10.06 billion, beating expectations of $9.48 billion and representing a ...